Meyka Pro banner
Ecora Royalties PLC

Stay Updated with the Latest Ecora Royalties PLC ECOR.TO News in Real Time

Find ECOR.TO news now at Meyka AI. Stay informed with the latest Ecora Royalties PLC stocks updates, including price news, market analysis, and expert insights.

ECOR.TO●TSX
Basic MaterialsIndustrial Materials
$3.02
$0.04(1.31%)
Canadian Market opens in 3h 41m
SiriusXM Comedy Backlash: 66% of Comedians Cut as Maniscalco Takes Over October 6
📅 13 days ago

SiriusXM Comedy Backlash: 66% of Comedians Cut as Maniscalco Takes Over October 6

SiriusXM replaced Raw Comedy with Sebastian Maniscalco’s channel, cutting 537 comedians from rotation. Working comics lost $15-per-spin royalties. Patton Oswalt, Michelle Wolf, and others demand restoration.

Read more 12
Shell Greenlights $33B LNG Canada Phase 2, Doubling Export Capacity to 28 Mtpa
📅 18 days ago

Shell Greenlights $33B LNG Canada Phase 2, Doubling Export Capacity to 28 Mtpa

Shell approves $33 billion LNG Canada Phase 2 expansion on September 29, doubling facility capacity to 28 mtpa by early 2030s. Meyka grades SHEL as A-rated Buy with 12-month forecast at $91.95.

Read more 12
Wendy’s Largest Franchisee Files Chapter 11 as Beef Costs, Discounts Crush Margins
📅 27 days ago

Wendy’s Largest Franchisee Files Chapter 11 as Beef Costs, Discounts Crush Margins

Meritage Hospitality, one of Wendy’s largest franchisees with 314 locations, files for Chapter 11 bankruptcy citing 48% earnings collapse, beef inflation, and weak marketing under prior leadership.

Read more 12
Tokyo Disneyland’s Villains Halloween Parade Draws Record Crowds Through October 31
📅 28 days ago

Tokyo Disneyland’s Villains Halloween Parade Draws Record Crowds Through October 31

Tokyo Disneyland’s Villains Halloween parade runs through October 31, 2026, featuring Disney villains in custom ponchos and elaborate costumes. Limited-time food and photo spots drive visitor traffic.

Read more 12
Hanmi Pharm (KRX: 128940) Hits 30% Daily Limit on $2.3B Obesity Drug Licensing Deal with Genentech  
📅 2 months ago

Hanmi Pharm (KRX: 128940) Hits 30% Daily Limit on $2.3B Obesity Drug Licensing Deal with Genentech  

Hanmi Pharm shares surged 30% on August 24, 2026, hitting the daily price limit after the South Korean drugmaker announced a licensing deal with Genentech worth up to $2.3 billion. The agreement covers HM17321, an experimental obesity treatment designed to reduce body fat while preserving muscle mass. Hanmi will receive $190 million upfront, while Genentech…

Read more 12
Pentagon Awards $560M Loan to Sunrise Energy for World’s First Scandium Mine in NSW
📅 2 months ago

Pentagon Awards $560M Loan to Sunrise Energy for World’s First Scandium Mine in NSW

Pentagon invests $560 million in Sunrise Energy Metals’ Syerston Scandium Project in NSW to counter China’s control of rare earth supply. Project targets aerospace and defence demand.

Read more 12
Goodwin Mulls Sale of Defence Engineering Division Supplying Submarine and Warship Components
📅 2 months ago

Goodwin Mulls Sale of Defence Engineering Division Supplying Submarine and Warship Components

On August 7, 2026, British engineering company Goodwin confirmed it is reviewing options for its defence engineering division, including the possible sale of a substantial part of the business. The division supplies critical components for UK and U.S. submarines and warships, making the announcement one of the most closely watched developments in the defence sector….

Read more 12
Holidays Disrupted as 11 UK Travel Companies Collapse in Recent Months
📅 2 months ago

Holidays Disrupted as 11 UK Travel Companies Collapse in Recent Months

UK travel firms have collapsed at an alarming rate in 2026. Since January, 11 operators have entered liquidation or ceased trading, according to industry reports. The wave spans coach tours, cruise specialists, and flight-and-hotel package providers. Thousands of holidaymakers now face cancelled trips and refund battles, while the sector confronts its sharpest instability in years….

Read more 12
HSBC (LSE: HSBA) to Sell Singapore Insurance Unit for £1.6B, Signs 15-Year Allianz Partnership
📅 3 months ago

HSBC (LSE: HSBA) to Sell Singapore Insurance Unit for £1.6B, Signs 15-Year Allianz Partnership

HSBC agreed to sell its Singapore life and health insurance business to Allianz on July 24, 2026. The deal values HSBC Life Singapore at S$2.7 billion, or roughly £1.6 billion. It will also enter a 15-year exclusive bancassurance partnership with the German insurer. The transaction generates a pre-tax gain of $1.8 billion and lifts HSBC’s…

Read more 12

ECOR.TO News FAQ